SCHEMBL4964416

SCHEMBL4964416

CC[Si](C)(C)OC(=O)CC(=O)O[Si](C)(C)CC

nearest known ligand 0.42

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
MGAM O43451 2/20 0.42
GAA P10253 2/20 0.42
SI P14410 2/20 0.42
MGAM2 Q2M2H8 2/20 0.42
TSHR P16473 4/20 0.39
ALDH1A1 P00352 1/20 0.31
HSD17B10 Q99714 1/20 0.31
MEN1 O00255 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6386912 0.88 TSHR (0.37) MGAMGAASIMGAM2TSHR
SCHEMBL6545301 0.84 TSHR (0.46) MGAMGAASIMGAM2TSHR
SCHEMBL4646599 0.82 TSHR (0.32) TSHR
SCHEMBL22558219 0.80 ALDH1A1 (0.38) TSHRALDH1A1HSD17B10
SCHEMBL4644358 0.80 TSHR (0.31) TSHR
SCHEMBL4641894 0.80 TSHR (0.31) TSHR
SCHEMBL6545156 0.80 TSHR (0.50) TSHRALDH1A1MEN1KMT2A
SCHEMBL4641761 0.78 TSHR (0.35) MGAMGAASIMGAM2TSHR
SCHEMBL4643606 0.77 TSHR (0.33) TSHRALDH1A1
SCHEMBL4644855 0.77 TSHR (0.33) TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080171802-A1 Methyltrialkylsilanes containing a cinnamate, cinnamamide, benzalmalonamide or benzalmalonate function and photostabilizing methods L'OREAL (FR) 2008-07-17 US disclosed
US-7354571-B2 Photoprotective compositions comprising methyltrialkylsilanes containing a cinnamate, cinnamamide, benzalmalonamide or benzalmalonate function L'OREAL (FR) 2008-04-08 US disclosed
EP-1594880-B1 PHOTOPROTECTIVE COMPOSITIONS BASED ON METHYLTRIALKYLSILANES CONTAINING A CINNAMATE, CINNAMAMIDE, BENZALMALONAMIDE OR BENZALMALONATE FUNCTION OREAL (FR) 2008-03-19 EP disclosed
US-20060018848-A1 Photoprotective compositions comprising methyltrialkylsilanes containing a cinnamate, cinnamamide, benzalmalonamide or benzalmalonate function L'OREAL (FR) 2006-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080171802-A1 Methyltrialkylsilanes containing a cinnamate, cinnamamide, benzalmalonamide or benzalmalonate function and photostabilizing methods KCNN1, KCNN2, CMBL MGAM 168/4885GAA 141/4885SI 320/4885
US-20060018848-A1 Photoprotective compositions comprising methyltrialkylsilanes containing a cinnamate, cinnamamide, benzalmalonamide or benzalmalonate function TRPM7, TRPM6, KCNN1 MGAM 575/4885GAA 369/4885SI 484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.